Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group

Few studies have examined the outcome of large numbers of patients with the microgranular variant (M3V) of acute promyelocytic leukemia (APL) in the all-trans retinoic acid era. Here, the outcome of 155 patients treated with all-trans retinoic acid–based therapy on 3 clinical trials, North American...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tallman, Martin S., Kim, Haesook T., Montesinos, Pau, Appelbaum, Frederick R., de la Serna, Javier, Bennett, John M., Deben, Guillermo, Bloomfield, Clara D., Gonzalez, Jose, Feusner, James H., Gonzalez, Marcos, Gallagher, Robert, Miguel, Jose D. Gonzalez-San, Larson, Richard A., Milone, Gustavo, Paietta, Elisabeth, Rayon, Chelo, Rowe, Jacob M., Rivas, Concha, Schiffer, Charles A., Vellenga, Edo, Shepherd, Lois, Slack, James L., Wiernik, Peter H., Willman, Cheryl L., Sanz, Miguel A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2010
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3031411/
https://ncbi.nlm.nih.gov/pubmed/20858857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-06-288613
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados